UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Estimating Individualized Treatment Rules Using Outcome Weighted Learning

Journal of the American Statistical Association, 2012-09, Vol.107 (499), p.1106-1118

2012

Volltextzugriff (PDF)

Bupropion and Naltrexone in Methamphetamine Use Disorder

The New England journal of medicine, 2021-01, Vol.384 (2), p.140-153

2021

Volltextzugriff (PDF)

Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report

Translational psychiatry, 2021-08, Vol.11 (1), p.417-417, Article 417

2021

Volltextzugriff (PDF)

Simultaneous rTMS and psychotherapy in major depressive disorder: Clinical outcomes and predictors from a large naturalistic study

Brain stimulation, 2018-03, Vol.11 (2), p.337-345

2018

Volltextzugriff (PDF)

Evidence-based guidelines for the interpretation of the 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR9) measure of suicidal risk

Journal of psychopharmacology (Oxford), 2024-09, Vol.38 (9), p.784-788

2024

Volltextzugriff (PDF)

Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature

Scientific reports, 2021-10, Vol.11 (1), p.21011-14, Article 21011

2021

Volltextzugriff (PDF)

Using the NIH Research, Condition and Disease Categorization Database for research advocacy: Schizophrenia research at NIMH as an example

PloS one, 2020-11, Vol.15 (11), p.e0241062-e0241062

2020

Volltextzugriff (PDF)

Ketamine for Treatment-Resistant Depression: Ready or Not for Clinical Use?

The American journal of psychiatry, 2013-10, Vol.170 (10), p.1079-1081

Rush, A. John

2013

Volltextzugriff (PDF)

The STARD Project results: a comprehensive review of findings

Current psychiatry reports, 2007-12, Vol.9 (6), p.449-459

2007

Volltextzugriff (PDF)

Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death

JAMA : the journal of the American Medical Association, 2010-05, Vol.303 (19), p.1946

2010

Volltextzugriff (PDF)

Anterior cingulate cortex in individuals with depressive symptoms: A structural MRI study

Psychiatry research. Neuroimaging, 2022-01, Vol.319, p.111420-111420, Article 111420

2022

Volltextzugriff (PDF)

Metabolomic and inflammatory signatures of symptom dimensions in major depression

Brain, behavior, and immunity, 2022-05, Vol.102, p.42-52

2022

Volltextzugriff (PDF)

Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin

The journal of clinical psychiatry, 2016-12, Vol.77 (12), p.e1639-e1646

2016

Volltextzugriff (PDF)

Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study

The American journal of psychiatry, 2011-07, Vol.168 (7), p.689-701

2011

Volltextzugriff (PDF)

Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STARD Report

The American journal of psychiatry, 2006-11, Vol.163 (11), p.1905-1917

2006

Volltextzugriff (PDF)

Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway

PloS one, 2013-07, Vol.8 (7), p.e68283-e68283

2013

Volltextzugriff (PDF)

A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project

Annals of family medicine, 2019-07, Vol.17 (4), p.326-335

2019

Volltextzugriff (PDF)

Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety—A Role for Bile Acids

Frontiers in neuroscience, 2022-07, Vol.16, p.937906-937906

2022

Volltextzugriff (PDF)

Common Genetic Variation and Antidepressant Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Genome-Wide Pharmacogenetic Studies

The American journal of psychiatry, 2013-02, Vol.170 (2), p.207-217

2013

Volltextzugriff (PDF)

Effect of Age at Onset on the Course of Major Depressive Disorder

The American journal of psychiatry, 2007-10, Vol.164 (10), p.1539-1546

2007

Volltextzugriff (PDF)

Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression

The New England journal of medicine, 2006-03, Vol.354 (12), p.1231-1242

2006

Volltextzugriff (PDF)

Medication Augmentation after the Failure of SSRIs for Depression

The New England journal of medicine, 2006-03, Vol.354 (12), p.1243-1252

2006

Volltextzugriff (PDF)

STARD: Revising Conventional Wisdom

CNS drugs, 2009-08, Vol.23 (8), p.627-647

2009

Volltextzugriff (PDF)

The Concise Health Risk Tracking ‐ Self‐Report (CHRT‐SR)—A measure of suicidal risk: Performance in adolescent outpatients

International journal of methods in psychiatric research, 2023-06, Vol.32 (2), p.e1944-n/a

2023

Volltextzugriff (PDF)

1 – 25 von 2.310

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.813)
Mit Volltextzugriff
(1.700)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.271)
Life Sciences & Biomedicine
(1.153)
Humans
(915)
Female
(650)
Male
(637)
Psychiatry
(579)
Adult
(513)
Biological And Medical Sciences
(504)
Medical Sciences
(468)
Middle Aged
(407)
Psychology. Psychoanalysis. Psychiatry
(331)
Depression
(284)
Aged
(267)
Psychopathology. Psychiatry
(259)
Treatment Outcome
(255)
Adolescent
(225)
Neurosciences & Neurology
(223)
Animals
(220)
Social Sciences
(194)
Adult And Adolescent Clinical Studies
(182)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Estimating Individualized Treatment Rules Using Outcome Weighted Learning

Bupropion and Naltrexone in Methamphetamine Use Disorder

The symptom‐specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta‐analysis

Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report

Simultaneous rTMS and psychotherapy in major depressive disorder: Clinical outcomes and predictors from a large naturalistic study

Evidence-based guidelines for the interpretation of the 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR9) measure of suicidal risk

Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature

Using the NIH Research, Condition and Disease Categorization Database for research advocacy: Schizophrenia research at NIMH as an example

Ketamine for Treatment-Resistant Depression: Ready or Not for Clinical Use?

The STARD Project results: a comprehensive review of findings

Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death

Anterior cingulate cortex in individuals with depressive symptoms: A structural MRI study

Metabolomic and inflammatory signatures of symptom dimensions in major depression

Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin

Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study

Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STARD Report

Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway

A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project

Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety—A Role for Bile Acids

Common Genetic Variation and Antidepressant Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Genome-Wide Pharmacogenetic Studies

Effect of Age at Onset on the Course of Major Depressive Disorder

Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression

Medication Augmentation after the Failure of SSRIs for Depression

STARD: Revising Conventional Wisdom

The Concise Health Risk Tracking ‐ Self‐Report (CHRT‐SR)—A measure of suicidal risk: Performance in adolescent outpatients

Suchergebnisse filtern